An updated review of lipid‐modifying therapy
LA Simons - Medical Journal of Australia, 2019 - Wiley Online Library
… has a low risk of muscle problems when used without statins. … Target LDL-C is still 1.8 mmol/L,
but more aggressive therapy with … Lipid interventions with statins lower cardiovascular risk. …
but more aggressive therapy with … Lipid interventions with statins lower cardiovascular risk. …
Cholesterol-lowering agents: statins—for everyone?
S Hadjiphilippou, KK Ray - Circulation research, 2019 - Am Heart Assoc
… statin therapy currently forms the mainstay of lipid-lowering … Ischemia Reduction With
Aggressive Cholesterol Lowering) … Although our risk prediction abilities have improved, problems …
Aggressive Cholesterol Lowering) … Although our risk prediction abilities have improved, problems …
Lipid lowering therapy: an era beyond statins
T Abdul-Rahman, SMA Bukhari, EC Herrera… - Current problems in …, 2022 - Elsevier
… Patients typically require a more aggressive lipid suppression medication … statin therapy,
certain patients may not achieve adequate reduction or may develop adverse effects to statins…
certain patients may not achieve adequate reduction or may develop adverse effects to statins…
Statin toxicity: mechanistic insights and clinical implications
NC Ward, GF Watts, RH Eckel - Circulation research, 2019 - Am Heart Assoc
… myopathy with other lipid-lowering therapy, high-dose statin therapy, … problems or report the
effect of statin therapy on CK levels. … aggression, agitation, irritability, mood changes, violent …
effect of statin therapy on CK levels. … aggression, agitation, irritability, mood changes, violent …
Lipid management beyond the guidelines
JG Robinson - Progress in cardiovascular diseases, 2019 - Elsevier
… Comparisons with other statin guidelines revealed that statin … Unfortunately, there are a
number of problems with the nonselective … In the Cholesterol Treatment Trialists individual meta-…
number of problems with the nonselective … In the Cholesterol Treatment Trialists individual meta-…
Statins: rationale, mode of action, and side effects
… implications that come with the aggressive reduction of its level in … to issue black-box warnings
on statins regarding the risk of … largest statin survey ever conducted by the National Lipid …
on statins regarding the risk of … largest statin survey ever conducted by the National Lipid …
Lipid-lowering therapy: guidelines to precision medicine
X Su, Y Cheng, D Chang - Clinica Chimica Acta, 2021 - Elsevier
… individual is based on the results of the analysis of … Regarding the adverse effects, the
musculoskeletal problems … who are intolerant with statins, further lipid-lowering therapies still need …
musculoskeletal problems … who are intolerant with statins, further lipid-lowering therapies still need …
State of the art comprehensive review of individual statins, their differences, pharmacology, and clinical implications
V Azemawah, MR Movahed, P Centuori… - … drugs and therapy, 2019 - Springer
… If more aggressive reductions are necessary, high-… statin use with various health-related
problems including cognitive impairment, participants were also on non-statin lipid-lowering …
problems including cognitive impairment, participants were also on non-statin lipid-lowering …
Current perspectives on the attainment of lipid modification goals relating to the use of statins and ezetimibe for the prevention of cardiovascular disease in the United …
TM Reynolds, A Pottle, SH Quoraishi - Vascular Health and Risk …, 2021 - Taylor & Francis
… updated to recommend more aggressive reduction of LDL-C … specific recommendations
(such as the exact lipid lowering … practice regarding setting specific lipid lowering goals, which …
(such as the exact lipid lowering … practice regarding setting specific lipid lowering goals, which …
Lipid-modifying drugs: pharmacology and perspectives
RX Xu, YJ Wu - Coronary Artery Disease: Therapeutics and Drug …, 2020 - Springer
… strategies of lipids modifying drugs (statins, proprotein … the problems are usually reversible
when the dose of statin is … PPARδ-specific agonists have revealed an important role for …
when the dose of statin is … PPARδ-specific agonists have revealed an important role for …